Dementia and Alzheimer’s Disease Treatment Market
Dementia and Alzheimer’s Disease Treatment
Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Dementia and Alzheimer’s Disease Treatment Market Size and Growth
The global Dementia and Alzheimer’s Disease Treatment market is projected to grow significantly due to the rising geriatric population and increasing awareness about the diseases. The market size is estimated to reach $12.8 billion by 2025. Key players in the market are focusing on developing innovative treatments to address the growing demand. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Novartis
◍ Pfizer, Inc.
◍ AbbVie Inc.
◍ Allergan plc
◍ Eli Lilly and Company
◍ F. Hoffmann-La Roche Ltd.
◍ AstraZeneca
◍ Biogen
◍ Eisai Co., Ltd.
◍ INmuneBIO
The Dementia and Alzheimer's Disease Treatment Market is highly competitive with key players like Novartis, Pfizer, AbbVie, Allergan, Eli Lilly, Roche, AstraZeneca, Biogen, Eisai, and INmuneBio. These companies develop, market, and sell drugs for Alzheimer's and dementia patients, which helps in the growth of the market.
- Novartis reported sales revenue of $48.7 billion in 2020.
- Pfizer Inc. reported sales revenue of $51.8 billion in 2020.
- AbbVie Inc. reported sales revenue of $45.8 billion in 2020.
Request Sample Report
Market Segmentation
By Application
Hospital
Clinic
Request Sample Report
By Product
Cholinesterase Inhibitors
Memantine
Combination Drugs
Market Growth
Request Sample Report
$ X Billion USD
